Arcus Biosciences, Inc. — Director's Dealing 2018

Oct 23, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2018-10-19

Reporting Person: Hege Kristen (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-19	Stock Option (right to buy)	$11.79	A	35000	Acquired	2028-10-18	Common Stock (35000)	Direct

Footnotes

F1: The option is exercisable in 36 equal monthly installments after October 19, 2018, subject to the Reporting Person's continued service to the Company.